Researchers say a new drug-delivery implant could help patients with hard-to-treat bladder cancer avoid losing their bladders — and stay cancer-free for years.
The investigational, potentially first-in-class agent tinostamustine (EDO-S101) has earned FDA orphan drug designation (ODD) ...
The Indian Council of Medical Research’s latest synthesis (covering up to 2023) estimates over 100 million Indian adults ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback